Neoadjuvant Therapy of Colorectal Liver Metastases: Lessons Learned from Clinical Trials

被引:14
|
作者
Brouquet, Antoine [1 ]
Nordlinger, Bernard [1 ]
机构
[1] Univ Versailles St Quentin Yvelines, Hop Ambroise Pare, AP HP, Dept Digest & Oncol Surg, Versailles, France
关键词
colorectal cancer; liver metastases; chemotherapy; OXALIPLATIN-BASED CHEMOTHERAPY; MULTICENTER RANDOMIZED-TRIAL; HEPATIC ARTERIAL INFUSION; LONG-TERM SURVIVAL; PHASE-III TRIAL; PREOPERATIVE CHEMOTHERAPY; SURGICAL RESECTION; 1ST-LINE TREATMENT; PATHOLOGICAL RESPONSE; FOLINIC ACID;
D O I
10.1002/jso.21657
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Neoadjuvant chemotherapy is increasingly used to improve outcome in patients with colorectal liver metastases (CLM). In patients with unresectable CLM, recent clinical trials evaluate the ability of chemotherapy to increase the resectability rate. In patients with resectable CLM, the objective is to decrease the risk of recurrence after hepatectomy that still remains elevated despite the improvement of the surgical technique. A multidisciplinary approach of patients with CLM is desirable whatever the initial status of resectability. J. Surg. Oncol. 2010; 102: 932-936. (C) 2010 Wiley-Liss, Inc.
引用
收藏
页码:932 / 936
页数:5
相关论文
共 50 条
  • [31] Lessons learned from the conduct of inpatient clinical trials in a pandemic
    O'Halloran, Jane A.
    Beitler, Jeremy R.
    Chung, Lucy K.
    Jain, Mamta K.
    Khan, Akram
    Merck, Lisa H.
    Mourad, Ahmad
    Oh, Minn A.
    Sharma, Shweta
    Yokum, Tammy
    Nayak, Seema U.
    JOURNAL OF CLINICAL AND TRANSLATIONAL SCIENCE, 2024, 8 (01)
  • [32] Moving forward in IPF: lessons learned from clinical trials
    Raghu, Ganesh
    Fleming, Thomas R.
    LANCET RESPIRATORY MEDICINE, 2024, 12 (08): : 583 - 585
  • [33] Lessons Learned From Clinical Trials of a Neurorehabilitation Therapy Based on tDCS, BMI, and Pedaling Systems
    Quiles, Vicente
    Ianez, Eduardo
    Ortiz, Mario
    Medina, Noelia
    Serrano, Antonia
    Azorin, Jose M.
    IEEE SYSTEMS JOURNAL, 2021, 15 (02): : 1873 - 1880
  • [34] Clinical risk scores in the current era of neoadjuvant chemotherapy for colorectal liver metastases
    Kumar, Rohan
    Dennison, Ashley R.
    Robertson, Vaux
    Jones, Michael J.
    Neal, Christopher P.
    Garcea, Giuseppe
    ANZ JOURNAL OF SURGERY, 2018, 88 (1-2) : E16 - E20
  • [35] CLINICAL RISK SCORE FOR PATIENTS WITH COLORECTAL LIVER METASTASES IN THE ERA OF NEOADJUVANT CHEMOTHERAPY
    Ayez, N.
    Lalmahomed, Z.
    Van Der Pool, A.
    Eggermont, A.
    IJzermans, J.
    Verhoef, C.
    DISEASES OF THE COLON & RECTUM, 2010, 53 (04) : 666 - 666
  • [36] Lessons Learned from Negative Clinical Trials Evaluating Antithrombotic Therapy for Ischemic Heart Disease
    Hyun-Jae Kang
    Matthew T. Roe
    Journal of Cardiovascular Translational Research, 2014, 7 : 112 - 125
  • [37] Gene therapy for ischemic cardiovascular disease:: Somes lessons learned from the first clinical trials
    Ylä-Herttuala, S
    Markkanen, JE
    Rissanen, TT
    TRENDS IN CARDIOVASCULAR MEDICINE, 2004, 14 (08) : 295 - 300
  • [38] Dosing of Renal Replacement Therapy in Acute Kidney Injury: Lessons Learned From Clinical Trials
    Bouchard, Josee
    Macedo, Etienne
    Mehta, Ravindra L.
    AMERICAN JOURNAL OF KIDNEY DISEASES, 2010, 55 (03) : 570 - 579
  • [39] Lessons Learned from Negative Clinical Trials Evaluating Antithrombotic Therapy for Ischemic Heart Disease
    Kang, Hyun-Jae
    Roe, Matthew T.
    JOURNAL OF CARDIOVASCULAR TRANSLATIONAL RESEARCH, 2014, 7 (01) : 112 - 125
  • [40] Clinical Trials for AKI: Lessons Learned From the ARDS Network
    Liu, Kathleen D.
    SEMINARS IN NEPHROLOGY, 2020, 40 (02) : 243 - 246